跳至主要内容
临床试验/CTRI/2021/03/031699
CTRI/2021/03/031699尚未招募未知

Evaluation of Efficacy and safety of topical Bimatoprost 0.03% solution in comparison to Tacrolimus 0.1% ointment in repigmentation of localized vitiligo

INDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with stable vitiligo(no progress of lesion and or development of new lesion during past 6 months)
  • Size of lesion should be less than 1% of body surface area
  • Less than or equal to 5 patches.
  • Patients on other treatment of vitiligo will be included only after wash out period of 1 week for topical and systemic drugs and 4 weeks for phototherapy

排除标准

  • a)Patients with lesion more than 1% of body surface area
  • b) Number of lesion equal or more than 6
  • c)Periocular lesion
  • d)Active infections
  • e) Allergic reaction to Bimatoprost or /Tacrolimus
  • f)Pregnancy and lactation.

研究者

相似试验